Martin R. Gaudinski

1 ta ish

National Institutes of Health

1. Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

   Melinda Hamer, Katherine V. Houser, Amelia R. Hofstetter +52

   Maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.346076